| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10018553 | HBV | ENSG00000171560.18 | protein_coding | FGA | No | No | 2243 | P02671 |
| TVIS10005139 | HBV | ENSG00000171560.18 | protein_coding | FGA | No | No | 2243 | P02671 |
| TVIS10017708 | HBV | ENSG00000171560.18 | protein_coding | FGA | No | No | 2243 | P02671 |
| TVIS10017489 | HBV | ENSG00000171560.18 | protein_coding | FGA | No | No | 2243 | P02671 |
| TVIS10017490 | HBV | ENSG00000171560.18 | protein_coding | FGA | No | No | 2243 | P02671 |
| TVIS10005140 | HBV | ENSG00000171560.18 | protein_coding | FGA | No | No | 2243 | P02671 |
| TVIS10005141 | HBV | ENSG00000171560.18 | protein_coding | FGA | No | No | 2243 | P02671 |
| TVIS10008153 | HBV | ENSG00000171560.18 | protein_coding | FGA | No | No | 2243 | P02671 |
| TVIS10008154 | HBV | ENSG00000171560.18 | protein_coding | FGA | No | No | 2243 | P02671 |
| TVIS10025297 | HBV | ENSG00000171560.18 | protein_coding | FGA | No | No | 2243 | P02671 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | FGA |
|---|---|
| DrugBank ID | DB01593 |
| Drug Name | Zinc |
| Target ID | BE0000538 |
| UniProt ID | P02671 |
| Regulation Type | |
| PubMed IDs | 3178229 |
| Citations | Marx G: Zinc binding to fibrinogen and fibrin. Arch Biochem Biophys. 1988 Oct;266(1):285-8. |
| Groups | Approved; Investigational |
| Direct Classification | Homogeneous transition metal compounds |
| SMILES | [Zn] |
| Pathways | Dihydropyrimidinase Deficiency; Rofecoxib Action Pathway; Losartan Action Pathway; AICA-Ribosiduria; Canavan Disease; Quinapril Action Pathway; Alkaptonuria; Eprosartan Action Pathway; gamma-Glutamyltransferase Deficiency; Pterine Biosynthesis; Sulindac Action Pathway; Rescinnamine Action Pathway; Piroxicam Action Pathway; Nabumetone Action Pathway; 2-Hydroxyglutric Aciduria (D and L Form); beta-Ureidopropionase Deficiency; Vitamin B6 Metabolism; Retinol Metabolism; Valsartan Action Pathway; Valdecoxib Action Pathway; Irbesartan Action Pathway; Adenosine Deaminase Deficiency; Hawkinsinuria; Methionine Metabolism; Ramipril Action Pathway; Benazepril Action Pathway; beta-Alanine Metabolism; Aspartate Metabolism; Diclofenac Action Pathway; Galactosemia |
| PharmGKB | PA451956 |
| ChEMBL | CHEMBL1201279 |
